CD8A and melanoma: In a study that analyzed CD8+ TILs from baseline tumor samples of 25 melanoma patients treated with nivolumab plus ipilimumab, researchers identified TCF1+PD-1+CD8+ T cells consistent with the Tex prog phenotype in almost all biopsies [79].